Jason Farley, PhD, MPH, ANP-BC, FAAN, AACRN

CRS:

JHU

Role:

Clinical

Position:

CTU Leader for HPTN Studies

Email:

jfarley1@jhu.edu

Dr. Jason Farley is both a Johns Hopkins University School of Nursing faculty member and a nurse practitioner in the Division of Infectious Diseases within the Johns Hopkins AIDS Service. He also holds an adjunct faculty appointment at the University of KwaZulu-Natal in Cape Town, South Africa. His current research assesses the epidemiologic interactions of patients with HIV and drug resistance infections in both domestic and international settings. His projects include an evaluation of treatment outcomes in patients with multi-drug resistant tuberculosis (MDR- TB) with a high HIV/AIDS prevalence in South Africa in collaboration with the Medical Research Council of South Africa. His team of researchers recently completed a country-wide assessment of knowledge, attitudes, and practices related to infection control in hospitals in South Africa.

The project successfully enrolled all 24 of the South African hospitals treating MDR-TB, and nearly 500 healthcare workers at these sites. In the U.S, he works to assess multidrug resistant Staphylococcus aureas (MRSA) colonization and infection among patients with HIV/AIDS in Maryland. He also is serving as the principal investigator on a grant exploring adherence to CVD guidelines in providers of HIV care within the Johns Hopkins AIDS Service and is a member of the editorial board of the American Journal of Infection Control.

  • HPTN Site Leader; Investigator of Record HPTN 069
  • Protocol team co-investigator HPTN 078
  • Investigator of Record HPTN 078
  • Farley J.E., Kelly A.M., Reiser K, Brown M, Kub J, Davis J.G., Van der Walt M. (2014). Development and evaluation of a nurse case management model to address HIV and MDR- TB in South Africa. PLoS One. (In press).
  • Tudor C, Van der Walt M, Margot B, Dorman B, Pan W, Yenokyan G, Farley J.E. (2014). Tuberculosis among healthcare workers in KwaZulu-Natal, South Africa: a retrospective cohort study. BMC Public Health 14:891. PMID 25174848.
  • Farley J.E., Landers TF, Godfrey C, Lipke V, Sugarman J. (2014). Optimizing the protection of research participants and personnel in HIV-related research where TB is prevalent: practical solutions for improving infection control. J Acquir Immune Defic Syndr (JAIDS). 65 Suppl 1: S19-23. PMID: 24321979.
  • *Farley, J.E., Murphy, J. Hayatt, M., Mark, H. (2013). Knowledge, Attitudes and Practice of OB/GYN Nurses and Auxiliary Staff in the Care of Pregnant Women Living with HIV. Journal of the Association of Nurses in AIDS Care (JANAC). 2(2):158-67. PMID: 23876818.
  • *Tudor, C., Van der Walt, M. Farley, J.E. (2013). Healthcare workers’ fears associated with working in M/XDR-TB wards in South Africa. International Journal of Tuberculosis and Lung Disease. 17 (10 Suppl 1):22-9. PMID: 24020597.
  • Moscou-Jackson, G., Commodore-Mensah, Y., Farley, J.E., DiGiacomo, M. (2013). Smoking Cessation Interventions in Persons Living with HIV or AIDS: A Systematic Review. Journal of  the Association of Nurses in AIDS Care (JANAC). 25(1):32-45. PMID: 23876816.
  • Anderson, J., Farley, J.E, Campbell, J. (2013). Interventions to Address HIV and Intimate Partner Violence in Sub-Saharan Africa. Journal of the Association of Nurses in AIDS Care  (JANAC). 24 (4):383-390. PMID: 23790280.
  • *Tudor, C., Van der Walt, M., Hill, M., Farley, J.E. (2013). Occupational Health Policies and Practices Related to TB in Health Care Workers in KwaZulu-Natal, South Africa. Public Health  Action. 3(2): online journal available at: http://dx.doi.org/10.5588/pha.12.0098.
  • *Van der Walt M, Lancaster J, Odendaal R, Davis J, Shean K, Farley JE. (2013). Serious Treatment Related Adverse Drug Reactions amongst Anti-Retroviral Naïve MDR-TB Patients. PLoS One, 8 (4) e58817. PMID: 2357319.
  • *Zimmerman CE, Stamper PD, Bryant L, Farley JE, Golova J, Holmberg R, Howard T, Linger Y, Myers L, Perov A, Ruby GB, Carroll KC, Chandler PD. (2012). Development of a Simple, Low Density Array to Detect Methicillin Resistant Staphylococcus aureus and mecA dropout. Journal of Microbiological Methods, E-pub: doi: 10.1016/j.mimet.2012.09.010. PMID: 23041495.
  • *Farley JE., Ross T, Krall J, Hayat M, Caston-Gaa A, Perl T, Carroll KC. (2012). Prevalence, Risk Factors and Molecular Epidemiology of MRSA Nasal and Axillary Colonization among Psychiatric Patients on Admission to an Academic Medical Center. American Journal of  Infection Control, E-pub: doi: 10.1016/j.ajic.2012.03.028. PMID: 22999771.
  • *Mphalele M, Tudor C, Van der Walt M, Farley JE. (2012). An Infection Control Audit of 10 Primary Healthcare Facilities in Western Cape, South Africa. International Journal of  Infection Control, 8(3): 1-5. PMID: None. Open access: http://www.ijic.info/.
  • *Wilson L, Harper DC, Tami I, Zarate R, Salas S, Farley JE, Warren N, Mendes I, Ventura C. (2012). Global Health Competencies for Nurses in the Americas. Journal of Professional  Nursing, 28(4): 213-222. PMID: 22818191.
  • *Farley JE, Tudor CT, Mphahlele M, Franz K, Perrin N.A, Dorman S, Van der Walt M. (2012). A National Infection Control Evaluation of M(X)DR-TB Hospitals in South Africa.  International Journal of Tuberculosis and Lung Disease, 16(1): 82-89. PMID: 22236851.

Categories

Leadership Committees
CRS
Roles

Clinical Trials

A5288: MULTIOCTAVE, Management Using the Latest Technologies...

The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...

Read More

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More

P1060:  Phase II, parallel, randomized, clinical trials...

A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...

Read More

A5332: Randomized Trial to Prevent Vascular Events in HIV...

REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....

Read More

P1073: Study of Immune Reconstitution Inflammatory Syndrome...

P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...

Read More